Using Beta-Blockers for Heart Attack Patients
Author Information
Author(s): Muacevic Alexander, Adler John R, Prakash Binayendu, Mohanta Reeta R, Kumar Santosh, Shah Mandar M
Primary Institution: Tata Main Hospital, Jamshedpur, IND
Hypothesis
This study aimed to analyze beta-blocker utilization patterns in ACS management and evaluate the impact of targeted improvement initiatives on their appropriate use in eligible ACS patients.
Conclusion
Targeted interventions can significantly enhance guideline adherence, optimizing ACS care in resource-limited settings.
Supporting Evidence
- Beta-blocker adherence improved from 74.5% to 92.7% post-intervention.
- Late initiation without valid reasons decreased from 15.5% to 3.6%.
- Non-initiation despite eligibility decreased from 10% to 3.6%.
- Targeted interventions included physician education and a standardized prescription checklist.
Takeaway
This study shows that teaching doctors about beta-blockers and using checklists can help more heart attack patients get the medicine they need on time.
Methodology
A two-phase study was conducted, with Phase I analyzing 1100 ACS patients' records and Phase II evaluating post-implementation outcomes of improvement measures.
Potential Biases
Potential bias due to physician hesitancy in treating patients with relative contraindications.
Limitations
The study was conducted at a single center, which may limit the generalizability of the findings.
Participant Demographics
Mean age of patients was 62 years; 24.5% were female and 75.5% were male.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website